Society ❯ Health Issues

Obesity

Public Health Weight Management Diabetes Chronic Diseases Treatment Options Public Perception Child Health Weight Loss Treatments Chronic Conditions Weight Loss

FDA Seeks To Drop Semaglutide, Tirzepatide, Liraglutide From 503B Bulks List

The move reflects a shift toward safety as approved supply returns.

Study Finds 11 Cancers Rising in Under-50s in England, With Obesity a Partial Driver

CMS Pauses Medicare GLP-1 Pilot After Insurers Balk, Sets 2026–27 Bridge

Obesity Before 30 Tied to Much Higher Risk of Early Death, Swedish Study Finds

Cause of Death Revealed for 'My 600-Lb. Life' Alum Dolly Martinez, 30

Study Finds Distinct Cardiometabolic Risks for Men and Women With Obesity

Trump Administration Urges Cutback on Ultra-Processed Foods and Sugar

Delhi Court Pauses DRL’s ‘Olymviq’ Rollout in Ozempic Trademark Fight

India Tightens Oversight of GLP-1 Drugs as Semaglutide Generics Proliferate

China Launches State-Led Weight-Loss Drive With 'Exchange Flab for Beef' Slogan

Aetna to Pay $117.7 Million to Settle DOJ Medicare Advantage False Claims Allegations

Rio Sets March 18 Launch for Public Semaglutide Care as Supplier Price Survey Opens

New Studies Refine GLP-1 Picture: Weight Rebounds After Stopping, With Hints of Lower Addiction Risk

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Government Offers GP Bonuses to Speed NHS Mounjaro Prescribing

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

Alton Towers Ordeal Prompted Michelle Stokes to Shed 12st with Slimming World

Tyson Backs HHS Rollout of New U.S. Dietary Guidelines, With Push to Update School Meals

Brazil’s Chamber Fast-Tracks Bill to Enable Compulsory Licensing of Tirzepatide Drugs

Mike Tyson Stars in Super Bowl Spot Urging ‘Eat Real Food’ as MAHA Promotes New Diet Guidance